medigraphic.com
ISSN 1561-3011 (Electronic)

2011, Number 4

<< Back

Rev Cubana Invest Bioméd 2011; 30 (4)

Complications of the automated and implantable cardioverterdefibrillator: arrhythmic electrical storm

Dorantes SM

Language: Spanish
References: 44
Page: 537-554
PDF size: 194.51 Kb.


ABSTRACT

The service of heart programmed electric stimulation and arrhythmias is national center of reference of patients with or without structural heart disease and malignant ventricular arrhythmias to specify exactly the diagnoses and to take the appropriate therapeutical measures, mainly the implantation of the automated cardioverter-defibrillator. From 24 years ago these devices are implanted observing the frequent of its complications (included the electric storm), coinciding with literature. An own series was designed whose data have been published and presented. Now, a panorama of the problem is tried. The device save the life and has precise indications, requiring an appropriate first decision because otherwise the risks are greater than the benefits. This device must to be implanted in who is necessary, but neither must to be placed without a precise indication, in someone who not goes used it but yes to face with all the problems thoroughout the life since once implanted nobody will be bold enough for to remove it.


REFERENCES

  1. Cannom DS, Prystowksy EN. Naspe history series. The evolution of the implantable cardioverter defibrillator. PACE. 2004;27:419-31.

  2. Josephson M, Wellens HJJ. Implantable defibrillators and sudden cardiac death. Circulation. 2004;109:2685-91.

  3. Sears SF, Conti JB. Review. Understarding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol. 2003;26:107-11.

  4. Jordaens LJ, Mekel JM. Editorial. Electrical storm in the ICD era. Europace. 2005;7:181-3.

  5. Credner SC, Klingenheben Th, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: Incidence, management and prognostic implications. JACC. 1998;32:1909-15.

  6. Freedberg NA, Hill JN, Fogel RI, Prystowsky EN. Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy. Implications for antiarrhythmic therapy and driving restrictions. JACC. 2001;37:1910-5.

  7. Krivan L, Kozák M, Sepsi M, Svobodnik A, Spinar J. Specific complications in the treatment with implantable cardioverter-defibrillators. Cas Lek Cesk. 2004;143:521-5.

  8. Emori T, Ohta K, Kusano K, Morita H, Matsubara H, Sano Sh, et al. Clusters of ventricular fibrillation in a patient with an implantable cardioverter defibrillator treated with amiodarona. Circ J. 2003;67:163-5.

  9. Salukhe TV, Dimopoulos K, Sutton R, Coats A-J, Piepoli M, Francis DP. Life-years gained from defibrillator implantation. Markedly nonlinear increase during 3 years of follow-up and its implications. Circulation. 2004;109:1848-53.

  10. Senesi M. Cardiodefibriladores. Indicaciones convencionales y no convencionales. En: Valero EM, ed. Tratamiento eléctrico de las arritmias. Marcapasos y cardiodefibriladores. Buenos Aires: Editorial Tiempo; 2000. p. 187-92.

  11. Saksena S, Breithardt G, Dorian P, Greene HL, Madan N, Block M. Non pharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials. Progress in Cardiovascular Diseases. 1996;38:429-44.

  12. Hauser RG, Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug administration manufacturer and user facility device experience database. Heart Rhythm. 2004;4:399-405.

  13. Saksena S, Madan N. Clinician update. Management of the patient with an implantable cardioverter-defibrillator in the third millennium. Circulation. 2002;106:2642-6.

  14. Exner DV, Pinski SL, Wyse G, Renfroe EG, Follman D, Gold M, et al. Electrical storm presages non sudden death. The antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001;103:2066-71.

  15. Pinski SL. Emergencies related to implantable cardioverter-defibrillators. Crit Care Med. 2000;28(10 suppl):N174-80.

  16. Gradaus R, Block M, Brachmann J, Breithardt G, Huber HG, June W, et al. Mortality, morbidity and complications in 3 344 patients with implantable cardioverter defibrillators: results from the german ICD registry EU RID. PACE. 2003;26[Pt 1]:1511-8.

  17. Pinski SL, Fahy GJ. Current perspectives. The proarrhythmic potential of implantable cardioverterdefibrillators. Circulation. 1995;92:1651-64.

  18. Healy E, Gyal S, Browning C, Robotis D, Ramaswamy K, Rofino-Nadoworny K, et al. Inappropriate ICD therapy due to proarrhythmic ICD shocks and hyperpolarization. PACE. 2004;27:415-6.

  19. Perkiomaki JS, Couderc J-PH, Daubert JP, Zareba W. Temporal complexity of repolarization and mortality in patients with implantable cardioverter defibrillators. PACE. 2003;26:1931-6.

  20. Duru F, Candinas R. Potential proarrhythmic effects of implantable cardioverterdefibrillators. Clin Cardiol. 1999;22:139-46.

  21. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, et al. Prevalence, predictors and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiology. 2004;15:1265-70.

  22. Mok N-Sh, Chan N-Y, Chiu A Ch-S. Successful use of quinidine in treatment of electrical storm in Brugada syndrome. PACE. 2004;27:821-3.

  23. Schliamser JE, Avramovitch NA, Karkabi B, Flugelman MY, Militianu A, Lewis BS. Rhabdomyolisis induced by repeated internal cardioverter defibrillator discharges. PACE. 2002;25:516-7.

  24. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J, et al. Electrical storm is an independent predictor of adverse long-term out come in the era of implantable defibrillator therapy. Europace. 2005;7:184-92.

  25. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace. 2000;2:263-9.

  26. Dorian P, Cass D. An overview of the management of electrical storm. Can J Cardiol. 1997;13(suppl A):13A-7A.

  27. Dorian P. Etiologies of electrical storm. Arch Mal Coeur Vaiss. 1997;90:27-31.

  28. Srivatsa UN, Ebrahimi R, El-Bialy A, Wachsner RY. Electrical storm: case series and review of management. J Cardiovasc Pharmacol Ther. 2003;8:237-46.

  29. Manolis AG, Katsivas AG, Vassilopoulos C, Tsatiris CG. Electrical storms in an ICD-recipient with 429 delivered appropriate shocks: therapeutic management with antiarrhythmic drug combination. J Interv Card Electrophysiol. 2002;6:91-4.

  30. Maury P, Couderc P, Delay M, Boveda S, Brugada J. Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace. 2004;6:130-3.

  31. Silva RMFL, Mont Ll, Nava S, Rojel U, Matas M, Brugada J. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. PACE. 2004;27:971-5.

  32. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med. 2003;138:445-52.

  33. Nakamura M, Isobe M, Imamura H. Incessant ventricular fibrillation attacks in a patient with Brugada syndrome. Int Jcardiol. 1998;64:205-6.

  34. Chalvidan T, Deharo JC, Dieuzaide P, Defaye P, Djiane P. Near fatal electrical storm in a patient equiped with an implantable cardioverter defibrillator for Brugada syndrome. PACE. 2000;23:410-2.

  35. Arya A, Haghjoo M, Dehghani MR, Fazelifar AF, Nikoo MH, Bagherzadeh A, et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol. 2006;97:389-92.

  36. Block M, Breithardt G: Long-term follow-up and clinical results of implantable cardioverter-defibrillators. En: Zipes DP, Jalife J ed. Cardiac Electrophysiology: From cell to bedside. Philadelphia: W.B. Saunders; 1995:1412-25.

  37. Sinha SK, Mehta D, Gomes JA: Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator. Mt Sinai J Med. 2005;72:1-9.

  38. Brigadeau F, Kouakam C, Klug D, Marquie C, Duhamel A, Mizon-Gerard F, et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter-defibrillators. Eur Heart J. 2006;27:700-7.

  39. Bettiol K, Gianfranchi L, Scarfo S, Pacchioni F, Pedaci M, Alboni P. Successful treatment of electrical storm with oral quinidine in Brugada syndrome. Ital Heart J. 2005;6:601-2.

  40. Pinter A, Dorian P. Approach to antiarrhythmic therapy in patients with ICDs and frequent activations. Curr Cardiol Rep. 2005;7:376-81.

  41. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006;97:1255-61.

  42. Tornés F, Cisneros P, Dorantes M, Castro J, Zayas R, Quiñones MA, et al. Tormenta eléctrica arrítmica en pacientes con cardioversor-desfibrilador automático implantable. Arch Cardiol Mex. 2008;78:68-78.

  43. Josephson ME. Electrophysiology at a crossroads. Heart Rhythm. 2007;4;658-61.

  44. Klein GJ. Electrophysiology at crossroads: a time of great opportunity. Heart Rhythm. 2007;4:662-4.




2020     |     www.medigraphic.com